Dunkel L, Taskinen S, Hovatta O, Tilly J L, Wikström S
Children's Hospital, University of Helsinki, Finland.
J Clin Invest. 1997 Nov 1;100(9):2341-6. doi: 10.1172/JCI119773.
Cryptorchidism results in impaired fertility. Reduced numbers of testicular germ cells can be shown histologically during the first years of life. The process causing germ cell loss in cryptorchid prepubertal boys is unknown, but it could be the result of a form of programmed cell death known as apoptosis. 25 adult men with a history of surgically treated cryptorchidism were studied, 15 of whom had received an unsuccessful human chorionic gonadotropin (hCG) therapy before orchidopexy. Apoptotic DNA fragmentation was assayed in testis biopsies taken during orchidopexy by end-labeling, both in extracted DNA and histochemically in situ. Only a few scattered apoptotic spermatogonias were seen by end-labeling of biopsies from patients not treated with hCG, whereas more extensive labeling of spermatogonia was seen after hCG treatment. As estimated by gel electrophoresis, the amount of low molecular weight DNA was 4.3-fold higher in the hCG-treated group when compared with the level in scrotal testis of non-hCG-treated patients (P < 0.001). About 20 yr after the biopsy, the low molecular weight DNA fragmentation correlated negatively with the testis volume (r = -0.84; P < 0.001) and positively with serum FSH levels (r = 0.73; P < 0.001). Findings in the semen analysis were similar between the groups. Apoptotic loss of spermatogonia after hCG treatment of cryptorchidism warrants reevaluation of the safety of this treatment.
隐睾症会导致生育能力受损。在生命的最初几年,组织学检查可发现睾丸生殖细胞数量减少。青春期前隐睾男孩生殖细胞丢失的过程尚不清楚,但可能是一种程序性细胞死亡形式即细胞凋亡的结果。对25名有手术治疗隐睾症病史的成年男性进行了研究,其中15人在睾丸固定术之前接受了人绒毛膜促性腺激素(hCG)治疗但未成功。在睾丸固定术期间采集的睾丸活检组织中,通过末端标记法对提取的DNA和组织化学原位法检测凋亡DNA片段化。对未接受hCG治疗患者的活检组织进行末端标记时,仅可见少数散在的凋亡精原细胞,而hCG治疗后可见精原细胞有更广泛的标记。通过凝胶电泳估计,hCG治疗组低分子量DNA的量比未接受hCG治疗患者阴囊内睾丸中的水平高4.3倍(P<0.001)。活检后约20年,低分子量DNA片段化与睾丸体积呈负相关(r=-0.84;P<0.001),与血清卵泡刺激素水平呈正相关(r=0.73;P<0.001)。两组精液分析结果相似。隐睾症经hCG治疗后精原细胞的凋亡性丢失值得重新评估这种治疗方法的安全性。